Trademark: 97459065
Word
VCTX211-ST
Status
Dead
Status Code
602
Status Date
Tuesday, May 30, 2023
Serial Number
97459065
Mark Type
4000
Filing Date
Wednesday, June 15, 2022
Abandoned Date
Friday, May 12, 2023
Trademark Owner History
CRISPR Therapeutics AG
Classifications
5 Cells for medical or clinical use; pharmaceutical and biopharmaceutical agents for the treatment of diabetes; gene therapy products, namely, gene transfer, regulation, modulation and delivery pharmaceuticals for the treatment of diabetes
42 Gene editing, namely, medical and scientific research for the treatment of genetic diseases and disorders; gene editing, namely, pharmaceutical research and development
VCTX 211 ST
VCTX TWO ONE ONE ST; VCTX TWO HUNDRED ELEVEN ST
Trademark Events
May 30, 2023
Abandonment Notice E-Mailed - Failure To Respond
May 30, 2023
Abandonment Notice Mailed - Failure To Respond
May 30, 2023
Abandonment - Failure To Respond Or Late Response
Feb 10, 2023
Notification Of Non-Final Action E-Mailed
Feb 10, 2023
Non-Final Action E-Mailed
Feb 10, 2023
Non-Final Action Written
Feb 7, 2023
Assigned To Examiner
Jun 28, 2022
New Application Office Supplied Data Entered
Jun 18, 2022
New Application Entered
POINT SUMMIT
MEXICAN AMERICAN ASSOCIATION
Trademark Alertz updated from USPTO on 2030-01-24

Trademark Alertz ™ - GRJR PTY LTD 2024 - Privacy Policy - Terms of Use

The information provided on Trademark Alertz is not legal or professional advice. Information may have been obtained from third parties and may contain errors. You must make your own enquiries and seek independent advice from relevant industry professionals before acting or relying on any information from Trademark Alertz. All trade mark information has been obtained from and made publicly available by The United States Patent and Trademark Office (USPTO). Copyright of the trademark data resides with USPTO. www.uspto.gov